Koji Nagafuji Selected Research

Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)

1/2022	Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation.
4/2018	Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission.
4/2017	Successful autologous peripheral blood stem cell transplantation in primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
6/2016	Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04).
4/2016	Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations.
8/2013	Autologous peripheral blood stem cell transplantation with granulocyte colony-stimulating factor combined conditioning regimen as a postremission therapy for acute myelogenous leukemia in first complete remission.
1/2013	Successful treatment of small cell variant anaplastic large cell lymphoma with allogeneic peripheral blood stem cell transplantation, and review of the literature.
8/2011	Correlation between pretreatment or follow-up CT findings and therapeutic effect of autologous peripheral blood stem cell transplantation for interstitial pneumonia associated with systemic sclerosis.
6/2010	Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry.
10/2009	Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koji Nagafuji Research Topics

Disease

13	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 12/2004
13	Neoplasms (Cancer) 01/2020 - 05/2003
12	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2018 - 01/2005
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2006
8	Lymphoma (Lymphomas) 01/2021 - 04/2003
7	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 10/2021 - 08/2010
7	Leukemia 04/2016 - 12/2006
6	Multiple Myeloma 07/2022 - 10/2010
6	Infections 01/2021 - 11/2003
4	Disease Progression 07/2022 - 11/2018
4	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 06/2012
4	Philadelphia Chromosome 09/2019 - 02/2013
4	Encephalitis (Encephalitis, Rasmussen) 01/2018 - 10/2007
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2016 - 02/2004
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2014 - 12/2004
4	Bronchiolitis Obliterans Syndrome 09/2009 - 11/2003
3	Fever (Fevers) 10/2022 - 11/2012
3	Anemia 02/2021 - 01/2007
3	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 05/2011
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2016 - 01/2006
3	Cytomegalovirus Infections (Inclusion Disease) 07/2012 - 04/2007
2	Thrombocytopenia (Thrombopenia) 10/2022 - 10/2010
2	Edema (Dropsy) 10/2022 - 06/2004
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2022 - 01/2019
2	Monoclonal Gammopathy of Undetermined Significance 07/2022 - 04/2016
2	Neutropenia 01/2021 - 07/2012
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 04/2013
2	Muscular Atrophy (Muscle Atrophy) 01/2021 - 06/2020
2	Acute Promyelocytic Leukemia 09/2020 - 09/2020
2	Residual Neoplasm 12/2019 - 09/2019
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2019 - 06/2009
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2018 - 01/2018
2	T-Cell Lymphoma (Lymphoma, T Cell) 04/2017 - 01/2010
2	Mycoses (Diseases, Fungus) 03/2013 - 03/2010
2	Hemorrhagic Cystitis 08/2012 - 03/2012
2	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2011 - 05/2011
2	Aspergillosis 07/2011 - 03/2010
2	Pain (Aches) 11/2010 - 10/2006
2	Heart Failure 04/2007 - 11/2003
1	Fibrosis (Cirrhosis) 10/2022
1	Multi-centric Castleman's Disease 10/2022
1	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 07/2022
1	Skin Diseases (Skin Disease) 07/2022
1	Pemphigus (Pemphigus Vulgaris) 07/2022
1	COVID-19 01/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Pathologic Constriction (Stenosis) 02/2021
1	Sclerosing Cholangitis 02/2021
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 02/2021
1	Febrile Neutropenia 01/2021
1	Inherited Blood Coagulation Disorders 09/2020
1	Stomach Neoplasms (Stomach Cancer) 06/2020
1	Inflammation (Inflammations) 06/2020

Drug/Important Bio-Agent (IBA)

9	Rituximab (Mabthera)FDA Link 01/2020 - 05/2003
4	Prednisolone (Predate)FDA LinkGeneric 10/2022 - 07/2008
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 01/2007
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010 - 12/2004
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2020 - 01/2018
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 03/2010
3	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 03/2010
3	Bortezomib (Velcade)FDA Link 12/2019 - 10/2010
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2019 - 10/2009
3	Calcineurin InhibitorsIBA 11/2019 - 10/2006
3	Lenalidomide (CC 5013)FDA Link 10/2019 - 04/2016
3	Immunosuppressive Agents (Immunosuppressants)IBA 10/2019 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 11/2018 - 12/2007
2	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2020
2	AutoantibodiesIBA 07/2022 - 01/2022
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 12/2007
2	Tyrosine Kinase InhibitorsIBA 02/2021 - 03/2015
2	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 03/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 12/2007
2	Prednisone (Sone)FDA LinkGeneric 12/2019 - 03/2010
2	Methylprednisolone FDA LinkGeneric 10/2019 - 10/2008
2	RNA (Ribonucleic Acid)IBA 05/2019 - 01/2019
2	Tacrolimus (Prograf)FDA LinkGeneric 02/2018 - 01/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018 - 05/2003
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 10/2009
2	Busulfan (Busulfex)FDA Link 09/2012 - 01/2005
2	Valganciclovir FDA Link 07/2012 - 03/2009
1	Reticulin (Reticular Fiber)IBA 10/2022
1	Immunoglobulin A (IgA)IBA 07/2022
1	defibrotideIBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2022
1	N 30IBA 10/2021
1	Serum AlbuminIBA 01/2021
1	romiplostim FDA Link 01/2021
1	Factor V (Coagulation Factor V)IBA 09/2020

Therapy/Procedure

26	Hematopoietic Stem Cell Transplantation 01/2022 - 11/2003
24	Transplantation 01/2022 - 12/2004
24	Drug Therapy (Chemotherapy) 10/2021 - 04/2003
21	Therapeutics 01/2022 - 11/2003
16	Stem Cell Transplantation 01/2021 - 11/2003
13	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2022 - 11/2003
8	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2016 - 04/2003
6	Cell Transplantation 10/2021 - 03/2012
4	Radiotherapy 04/2016 - 05/2003
1	Length of Stay 01/2021